Position in HLN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2
+$0 QoQ
Shares Held
253
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#637
of 639 holders
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $305,026 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (0.0% of the industry book) .
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2 | 253 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $2 | 249 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3 | 249 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $2 | 249 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3 | 248 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3 | 245 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2 | 245 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3 | 245 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,015 | 244 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,046 | 241 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,983 | 241 | Shares | Defined | 2024-01-30 | |
| 2022-09-30 | $1,425 | 234 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||